BioNexus Gene Lab Corp Common stock
BGLCBioNexus Gene Lab Corp (BGLC) is a biotechnology company specializing in genetic research and development. The firm focuses on advancing genetic engineering, biotechnology applications, and healthcare innovations, aiming to improve diagnostics, treatment, and therapeutics through cutting-edge genetic technologies.
Company News
BioNexus Gene Lab Corp entered a strategic partnership with BirchBioMed Inc. to invest $10 million and collaborate on advancing FS2 topical platform in Southeast Asia, focusing on dermal regeneration and fibrosis control.
BioNexus Gene Lab Corp. (BGLC) filed its 2024 annual report, showcasing strategic realignment, technological advancement, and improved financial performance. The company highlighted its blockchain-native treasury strategy, expansion of genomic diagnostics offerings, and partnerships to scale its AI-based health diagnostics initiatives.
KUALA LUMPUR, Malaysia, April 20, 2024 (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corporation (NASDAQ: BGLC), peneraju global dalam diagnostik genomik dan teknologi penjagaan kesihatan, mengumumkan pelaburan strategik melalui anak syarikat milik penuh mereka, MRNA Scientific Sdn Bhd, dalam Ascension Innovation Sdn Bhd (AISB), sebuah syarikat persend...
BioNexus Gene Lab Corp. Agrees to Invest RM 1.2 million in Ascension Innovation (AISB) to Advance Digital Health Innovation through AI adoption
Shares of Sony Group Corporation (NYSE: SONY) fell during Wednesday’s session after the company reported third-quarter financial results and revised guidance above estimates and shared plans to list its financial arm in October 2025. Sony Group reported third-quarter FY23 sales growth of 22% year-on-year to $25.34 billion (¥3.75 trillion), be...
